• Cambodia
  • India
  • Kazakhstan
  • Kenya
  • Malaysia
  • Moldova
  • Myanmar
  • Philippines
  • Tajikistan
  • Ukraine
  • Uzbekistan
  • Vietnam

Pharmacovigilance

Pharmacovigilance

Pharmacovigilance

Kusum Healthcare has a strong commitment to manufacturing quality products. Our aim is to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines

A comprehensive adverse event reporting database is maintained in order to ensure compliance regulations are met globally. Please help us by filling the form below in the event of adverse reactions. This information helps in continuous assessment of the benefit-risk ratio of medicines.

What is to be reported?

Customers or healthcare professionals can report ‘Any Adverse Experience / Side Effect’ experienced after taking Kusum Healthcare’s medicine/s.

Who can report?

Healthcare professionals (doctors, dentists, nurses and pharmacists) and non-healthcare professional (Patient, relative and friends)

Confidentiality

The patient’s identity and the information provided is held in strict confidence and used only for research purpose. The company shall not disclose the reporter’s identity in response to a request from the public.

ALL PROVIDED INFORMATION IS CONFIDENTIAL AND NON-DISCLOSURE
WITH THE EXCEPTION OF THE CASES STIPULATED BY LAW



MaleFemale

YesNoUnknown

YesNoUnknown

Yes



YesNo


SUSPECTED DRUG(S)









OTHER DRUGS (Taken within the last 3 months)









SUSPECTED ADVERSE DRUG REACTION(S) (ADR)




YesNoUnknown

YesNoUnknown

ACTION TAKEN TO TREAT THE ADR

NoneDrug withdrawalDose reducingCo-treatment cessationMedicinal therapyNon-medicinal therapy (including surgical intervention)Other (indicate):

YesNo

OUTCOME

Recovering without consequencesImprovement of stateState without changesDeath related to the ADRDeath not related to the ADRRecovering with the consequences (indicate):Unknown

CRITERIA OF SERIOUSNESS


Hospitalization – Initial or prolongedLife threateningDisabilityProlongation of outpatient therapyCongenital malformationClinically significant condition (indicate):

INFORMATION ABOUT THE REPORTER (Person who informed about the ADR)

DoctorMedical RepresentativeProfessional belongingPharmaceuticalClinically significant condition (indicate):